Related Experiment Videos
Laser photocoagulation for macular soft drusen. Updated results
M S Figueroa1, A Regueras, J Bertrand
1Department of Ophthalmology, Rámon y Cajal Hospital, Madrid, Spain.
Retina (Philadelphia, Pa.)
|January 1, 1997
Summary
Laser treatment effectively cleared soft drusen in age-related macular degeneration (AMD). However, it did not significantly reduce the risk of choroidal neovascularization, suggesting potential benefits only in early-stage AMD.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Medical Treatments
Background:
- Age-related macular degeneration (AMD) is a leading cause of vision loss.
- Soft drusen and pigmentary changes are indicators of AMD progression.
- Choroidal neovascularization (CNV) is a severe complication of AMD.
Purpose of the Study:
- To evaluate the efficacy of laser treatment on macular soft drusen disappearance in AMD.
- To assess the impact of laser treatment on the development of CNV.
- To update findings on the natural evolution of AMD after drusen treatment.
Main Methods:
- Prospective study of 46 patients with confluent soft drusen and pigmentary changes.
- Group 1: 30 patients with bilateral drusen, one eye treated, one control.
- Group 2: 16 patients with existing CNV in one eye, fellow eye treated. Argon green laser applied to temporal macula drusen.
Main Results:
- Treated drusen disappeared in an average of 3.5 months; untreated drusen in 8.5 months.
- After 3 years, CNV developed in one control eye vs. none in treated eyes (Group 1).
- CNV occurred in 18% of Group 2 patients. Initial visual acuity gains diminished due to cataract.
Conclusions:
- Laser treatment appears effective for soft drusen disappearance.
- Treatment did not significantly reduce CNV risk in eyes with prior exudative disease.
- Potential benefit observed for high-risk bilateral soft drusen in earlier AMD stages.